Vaccine to pathogenic immune activation cells during infections
US11957748B2 · kind B2 · utility
0Cited by
2References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 28, 2021 |
| Grant date | Apr 16, 2024 |
| Priority date | — |
| Expiry date | Dec 7, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for preventing an infectious disease in a subject in need thereof. In particular the method includes the administration of a combination, pharmaceutical combination, medicament or kit-of-parts including a first part including a CD8 vaccine specific for at least one infectious disease-related antigen, optionally a second part including an interferon alpha blocking agent, and a third part including a type III interferon and/or an agent stimulating the production of type III interferon.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.